Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05127616 · ClinicalTrials.gov registry record · NA

EPPIC: Easing Pelvic Pain Interventions Clinical Research Program

A NA study of Chronic Pain and Interstitial Cystitis, sponsored by State University of New York at Buffalo.

Recruiting
Registry status
NA
Development phase
240
Enrollment target
3
Study locations

NCT05127616: Recruiting NA study of Chronic Pain and Interstitial Cystitis, sponsored by State University of New York at Buffalo.

NCT05127616 is a NA study of Chronic Pain and Interstitial Cystitis that is actively recruiting participants, run by State University of New York at Buffalo. The registered enrollment target is 240 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (69% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05127616, a NA study of Chronic Pain and Interstitial Cystitis, is actively recruiting participants, sponsored by State University of New York at Buffalo.

RECRUITING
Registry status
NA
Development phase
240 participants
Enrollment target
3
Study locations

Study Summary

The EPPIC (Easing Pelvic Pain Interventions Clinical Research Program) study evaluates an ultra-brief, 4 session cognitive behavioral pain treatment transdiagnostic in design for urologic chronic pain syndrome (UCPPS) with clinical and practical advantages over existing behavioral therapies whose length and focus limits their adoption by clinicians and coverage for mechanistically similar comorbidities. A theoretically informed, practical, empirically grounded approach will systematically unpack CBT's working mechanisms, clarify for whom it works, ease dissemination, appeal to patients, providers, payers, and policy makers in the COVID-19 era favoring low resource intensity treatments, and reduce cost and inefficiencies associated with high intensity therapies whose complexity, length, and scarcity restricts uptake and impact.

Primary Outcome

Widely used measure of global improvement of symptoms from baseline. To optimize rigor, clinician version by independent MD assessors "blind" to treatment assignment will also measure global severity of pelvic pain and urinary symptoms from baseline and validate patient-reported global improvement as a marker of clinical response. Global improvement is a core domain recommended for conducting clinical trials of the efficacy and effectiveness of treatments for chronic pain according to Initiative

Interventions

  • BEHAVIORAL Minimal Contact-Cognitive Behavior Therapy
  • BEHAVIORAL Patient Education/Support

Study Locations (3)

California

  • UCLA - Los Angeles

Michigan

  • University of Michigan - Ann Arbor

New York

  • University at Buffalo (the only clinical site where treatment is delivered) - Buffalo

Trial Details

FieldValue
Enrollment Target 240 participants
Start Date 2022-08-10
Est. Completion 2028-07-31
Phase NA

What NCT05127616 shows while recruiting

NCT05127616 is an interventional study that assigns participants to a tested intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (69% lower).

The record links to 7 conditions, with Chronic Pain appearing as the primary indexed condition, and to 2 interventions - of which Minimal Contact-Cognitive Behavior Therapy is the first listed.

NCT05127616 reports a single indexed study location in California, Michigan, New York.

Frequently Asked Questions

What is clinical trial NCT05127616 about?

NCT05127616 is a clinical study titled "EPPIC: Easing Pelvic Pain Interventions Clinical Research Program". The EPPIC (Easing Pelvic Pain Interventions Clinical Research Program) study evaluates an ultra-brief, 4 session cognitive behavioral pain treatment transdiagnostic in design for urologic chronic pain syndrome (UCPPS) with clinical and practical advantages over existing behavioral therapies whose le...

What is the current status of trial NCT05127616?

This trial is currently recruiting. It is a NA study. The enrollment target is 240 participants. The study started on 2022-08-10. Estimated completion is 2028-07-31.

What conditions does trial NCT05127616 study?

This clinical trial studies the following conditions: Chronic Pain, Interstitial Cystitis, Bladder Pain Syndrome, Chronic Pelvic Pain Syndrome, Chronic Prostatitis.

What interventions are being tested in trial NCT05127616?

The interventions under investigation include: Minimal Contact-Cognitive Behavior Therapy (BEHAVIORAL), Patient Education/Support (BEHAVIORAL).

Who is sponsoring clinical trial NCT05127616?

This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05127616 being conducted?

This trial has 3 study locations across California, Michigan, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05127616's enrollment target sits among peer trials

240 68th of 301 higher than 231 of 301 other Chronic Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02855554 · 240 participants · NA

    Quantitative Cardiac Parametric Mapping

  • NCT03230565 · 240 participants · Phase 4

    Continuous Infusions vs Scheduled Bolus Infusions

  • NCT03399929 · 240 participants

    Traumatic Brain Injury and Stroke Long Term Outcome

  • NCT03583710 · 240 participants · Phase 3

    Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05127616, the US trial registry maintained by the National Library of Medicine. NCT05127616 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.